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We studied the time-resolved polarization-dependent fluorescence spectroscopy of receptor-targeted con-
trast agents (Cybesin and Cytate) bound with prostate cancer cells in prostate tissue. An analytical mod-
el dealing with highly viscous tissue media was developed and used to investigate the rotation times and
fluorescence anisotropies of the receptor-targeted contrast agents in prostate tissue. The differences of
rotation times and fluorescence anisotropies were observed for Cybesin (Cytate) in cancerous and normal
prostate tissues, which reflect changes of the microstructures of cancerous and normal tissues and their
different bound affinity with contrast agents. The preferential uptake of Cytate (Cybesin) in cancerous
tissue was used to image and distinguish cancerous tissue areas from normal tissue areas. The fluor-
escence polarization difference imaging technique was used to enhance the image contrast between
the cancerous and normal tissue areas. This research may help to introduce a new optical approach
and criteria for prostate cancer detection. © 2011 Optical Society of America
OCIS codes: 170.6510, 170.6930, 170.3880, 300.6500.
1. Introduction
Prostate cancer has a high incidence and mortality
rate for men. In 2009, new cases of prostate cancer
were diagnosed nearly 192,280 times, ranking as
No. 1 of new cancer incidence for men in the U.S. [1].
Inspired by the initial research of Alfano’s group in
the 1980s [2], fluorescence spectroscopy has been
widely studied as an optical tool for cancer diagnosis.
Time-resolved fluorescence polarization spectro-
scopy measures the temporal intensity profile and
degree of emission polarization within its lifetime,
and it provides information not only of the location
of abnormalities but also their biophysical micro-
environments [3,4]. The use of intrinsic chromo-
phores to differentiate optical properties of diseased
and healthy human tissues is limited by their ultra-
violet bands [5], which are not in the near-infrared
(NIR) range of “tissue optical window” [6].
Recent progress in biomedicine has shown that
attachment of the optical dyes emitting desirable
wavelengths to small molecular peptides (ligand)
can be used to target overexpressed receptors on cer-
tain tumors without loss of receptor affinity of the
ligand [7]. Two kinds of receptor-targeted contrast
agents, namely Cybesin and Cytate, were demon-
strated to target the overexpressed bombesin re-
ceptor (BR) [8] and somatostatin receptor (SSTR)
[9], respectively, on prostate cancer tissues in vitro
[10,11]. The advantages of optical receptor-targeted
contrast agents include a high affinity of specific
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ligand corresponding to overexpressed receptor for
the localization of tumors [7], rapid clearance of the
applied contrast, possibilities of preparing a library
of peptides for rapid identification of bioactive mole-
cules [7], and preservation of spectral advantage in
the NIR range of the “tissue optical window” [10,11].
Time-resolved polarization-dependent fluorescence
spectroscopy provides not only the intensity informa-
tion but also relaxation and rotation information of
fluorophores in the microenvironment of media [3].
Gleason grades for prostate cancer stages indicate
that there are different microstructures of can-
cerous prostate tissue in comparison with normal
prostate tissue: high cell density, nonuniform cell
distribution, and enlarged nuclei size in cancerous
tissue [12].
In this study, an analytical model was developed
and used to describe the time-resolved polar-
ized fluorescence kinetics of the contrast agents
(Cybesin and Cytate) in prostate tissue. The rotation
times and fluorescence anisotropies of the receptor-
targeted contrast agents in stained cancerous and
normal prostate tissues were extracted using this
analytical model with the measured time-resolved
polarized fluorescence data. The differences of ro-
tation times and fluorescence anisotropies were ob-
served for Cybesin (Cytate) in cancerous and normal
prostate tissues. These differences reflect changes of
microstructures of cancerous and normal tissues,
and a much larger portion of contrast agents conju-
gated with the cancerous cells than that with the
normal.
2. Experimental Samples and Method
The experimental arrangement of the time-resolved
fluorescence measurements has been reported else-
where [3]. Ultrafast 130 fs laser pulses at 800nm
were generated with a repetition rate of 82MHz from
a mode-locked Ti:sapphire laser system and used to
pump the samples (Cybesin- and Cytate-stained can-
cerous or normal prostate tissues). The fluorescence
was collected by a lens with 5 cm focus length into a
synchroscan streak camera with a temporal resolu-
tion of 10ps. An 830nm long pass filter was used
to cut off the illuminating light so that only the emis-
sion from the sample was recorded. Two polarizers
(P1 and P2) were used. P1 was used to ensure the lin-
ear polarization of the input laser pulses and P2 used
as an analyzer. The polarization of P2 was rotated
from 0° to 90° with respect to that of P1 to record the
intensity profiles of the parallel and perpendicular
polarization components of the fluorescence. The
temporal profiles recorded by a silicon-intensified
target of the streak camera were analyzed to ob-
tain temporal and polarization information of the
fluorescence.
Cybesin (Cytate) was synthesized by Achilefu’s
group at the Washington University School of Med-
icine. Cybesin (Cytate) is mainly composed of ICG
(an FDA-approved NIR dye) and the BR (SSTR)
ligand, which delivers ICG to the corresponding re-
ceptors overexpressed in tumor [7]. Human prostate
tissues were obtained from the Co-operation Human
Tissue Network (CHTN) and the National Disease
Research Interchange (NDRI) under the approval
of the Institutional Review Board at The City College
of the City University of New York. Each pair of can-
cerous and normal prostate tissue samples was
taken from the same patient, and diagnosed by a
pathology medical doctor. Samples were neither
chemically treated nor were frozen prior to the ex-
periments. The time elapsed between tissue re-
section and measurements may vary for different
sample sources. However, the maximum elapsed
time is less than 30h. The preparation of prostate
tissue samples used for time-resolved studies follows
this protocol: (1) samples (cancerous and normal
prostate tissues) were cut into ∼2 × ∼1 × ∼0:5 cm
ðlength × width × thicknessÞ pieces, (2) samples were
soaked in the same aqueous Cybesin (Cytate) with a
concentration of ∼3:2 × 10−6M for ∼10 min, (3) sam-
ples were put into sodium phosphate buffer (Sigma-
Aldrich) to wash off and consequently reduce the
amount of unbound Cybesin (Cytate) in particular
on the surface and subsurface. Six pairs of samples
were investigated for Cybesin targeting to overex-
pressed BR [7,8,10] in cancerous tissue and six for
Cytate to SSTR [7,9,11]. For each prostate tissue
sample, three to six different locations were mea-
sured to get an average value.
The spectral polarization imaging set up used for
imaging Cybesin- and Cytate-stained cancerous and
normal prostate tissues has been described in our
early work [10]. Light from a white light source is
used to illuminate the prostate tissue sample with
average power of ∼50 μW=cm2. The wavelengths
of the pump and detection are selected using wide-
band pass filters varying from 550 to 900nm with
FWHM ¼ 40nm. A CCD camera records images
formed by light emitted from the sample. Polarizers
were used to obtain parallel and perpendicular
images relative to the polarization direction of the
illuminating light.
A typical cancerous/normal prostate tissue sample
used for the imaging measurements consists of a
small piece of cancerous prostate tissue and a small
piece of normal prostate tissue. They were first
soaked in the same aqueous Cybesin (Cytate) with
a concentration of ∼3:2 × 10−6M for ∼10 min and
then put into sodium phosphate buffer (Sigma-
Aldrich) to wash off the unbound Cybesin (Cytate).
The stained cancerous and normal tissues were then
covered by a large piece of ∼0:5mm thick normal
prostate tissue.
3. Analytical Model
A. Picosecond Rotational Diffusion Kinetic and
Time-Resolved Fluorescence of Dyes in Solution
Picosecond rotational kinetic fluorescence spectro-
scopy is widely used to investigate the rotational
motion of fluorophores in solution [13,14]. The
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time-resolved polarization measurements of fluoro-
phores excited with linearly polarized light can be
applied as a probe to determine the rotation rate
of dye molecules, which is a function of the viscosity
and temperature of the environment, and the size of
rotating molecule [13]. The ultrafast rotation
dynamics of fluorophores can be used to extract
the information of the surrounding medium [3].
The fluorescence depolarization property is usually
described by the time-resolved fluorescence anisotro-
py, defined as [13,14]:
rðtÞ ¼ I∥ðtÞ − I⊥ðtÞ
I∥ðtÞ þ 2I⊥ðtÞ
; ð1Þ
where I∥ðtÞ and I⊥ðtÞ are the emission intensities of
the fluorescent components whose polarizations are
parallel and perpendicular to the polarization direc-
tion of the excited light, respectively [13,14]. Equa-
tion (1) shows the relationships between the time
evolution of rðtÞ and the measured intensities of
the fluorescence components, I∥ðtÞ and I⊥ðtÞ. The de-
polarization feature of emission from contrast agents
in solvent is realized to be mainly caused by Brow-
nian rotation [13–15]. Therefore, it is possible to
determine the rotation rate of molecules from mea-
sured I∥ðtÞ and I⊥ðtÞ. The picosecond polarized fluor-
escence of a dipole can be described by a set of
equations containing two parameters: the decay rate
of the emission of their excited state (reflecting the
dipole’s lifetime) and the transport rate of the emis-
sion from one orthogonal component to another (re-
flecting the dipole’s rotation time) [9]. The decay of
the parallel [I∥ðtÞ] and perpendicular [I⊥ðtÞ] compo-
nents of the fluorescence excited by a linear polarized































where I0 is the initial emission intensity, τf is the
fluorophore’s lifetime, τr is the rotation time affecting
the depolarization rate of the emission of the excited
polarized molecules, and r0 is the initial fluorescence
anisotropy at t ¼ 0 reflecting the initial orientation of
the dipoles. Substituting Eq. (2) into (1), rðtÞ can be
written as [13]:







Equation (3) indicates that the decay behavior of
rðtÞ is noted to reflect the dipole’s rotation time (τr)
but independent of the fluorescence lifetime (τf ) of
the molecules [13]. Theoretical calculation of r0 is
based on the physical phenomenon of photoselection:
the population of excited fluorophores partially or-
iented along the parallel direction. The theoretical
value of r0 was calculated and reported to be 0.4
in solution [13–15]. In the simple possible case where
molecules undergo Brownian rotation as Einstein






where K is the Boltzmann constant, T is the absolute
temperature, η is the viscosity of solvent, and V is the
volume of a molecule.
The total fluorescence intensity IðtÞ can be written
as:







where the factor of 2 is used for counting the contri-
bution of the two perpendicular components to the
whole fluorescence intensity because the dipoles’
Brownian motion happens in 3D space. Equation (5)
indicates that the temporal profiles of the total emis-
sion intensity IðtÞ depends only on I0 (the initial
emission intensity) and τf (the fluorophore’s lifetime)
but not on τr (the dipole’s rotation time).
B. Analytical Model: Static and Time-Resolved
Components of Fluorescence Anisotropy of Receptor-
Targeted Contrast Agents in Prostate Tissues
In order to investigate the time evolution of emission
from receptor-targeted contrast agents (Cybesin and
Cytate) bound with prostate cancer cells [7,10,11] in
prostate tissue, an analytical model dealing with
high viscous media was developed. It is well known
that the properties of biological living tissues are
somehow similar to the behavior of liquid with very
high viscosity [16,17], and the human body has a vol-
ume of 70% to 80% water. Experimental results also
indicated that dye in highly viscous tissues is ex-
pected to have an ordered structure to cause the dif-
ferent distribution of the initially excited fluorescent
molecules while the time-resolved fluorescence po-
larization spectroscopy is measured [18]. The viscos-
ities of prostate tissue were reported to be much
higher than 3000P [19]. Cybesin (Cytate) in prostate
tissue can be considered as a fluorescent contrast
agent in “highly viscous liquid.”
After cancerous prostate tissue was soaked into
the Cybesin (Cytate) solution and washed off using
sodium phosphate buffer consequently, a large pro-
portion of Cybesin (Cytate) was conjugated to the cor-
responding receptor on cells [7,10,11]. Although a
large amount of free Cybesin (Cytate) molecules in
surface and subsurface were removed by the buffer,
some free contrast agents were still conserved in the
deep tissue area. For the case of normal prostate tis-
sue, a smaller portion of contrast agent was conju-
gated to tissue cells in comparison with cancerous
tissue [7,10,11], and some free fluorescent molecules
exist in the interstitial fluid of deep tissue areas. The
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cell-bound mechanism and reorientation of Cybesin
(Cytate) molecules in prostate tissue is schematically
shown in Fig. 1. This model describes two types of
bound and unbound situations of Cybesin (Cytate)
molecules in Cybesin (Cytate)-stained prostate tis-
sues and their contributions to total fluorescence
and fluorescence anisotropy.
As shown in Fig. 1, the emission of Cybesin
(Cytate) can be considered to be contributed from
two components: (i) static component caused by
cell-bound Cybesin (Cytate) molecules in the pros-
tate tissue and (ii) the temporal component contrib-
uted by the unbound Cybesin (Cytate) molecules that
remain in the body liquid of prostate tissue and can
undergo rotation. These assumptions are reasonable,
because the weights of tissue cells are much larger
than that of Cybesin (Cytate) molecules, and tissue
cells are too huge to undergo rapid rotation. There
are more cell-bound Cybesin (Cytate) molecules in
cancerous prostate tissue than those in normal tis-
sue, as indicated in Fig. 1, because of the overex-
pressed receptors on the prostate cancer cells and
the highly bound affinity of the contrast agents to
the corresponding receptors [11–15]. The free con-
trast agent molecules would undergo rotation, while
the Cybesin (Cytate) molecules conjugated to the
tissue cell would stay steady.
We consider a system of n types of noninteracting
fluorophores and investigate the rotational dynamics
and fluorescence anisotropies of the contrast agents
Fig. 1. (Color online) Schematic diagrams of the cell-boundmechanism and reorientation of Cybesin (Cytate) molecules in stained (a) can-
cerous tissue, which has a higher cell density andmore cell-bound Cybesin (Cytate) molecules, and (b) normal tissue, which has a lower cell
density and less cell-bound Cybesin (Cytate). Molecules with their absorption transition vectors (arrows) aligned parallel to the linearly
polarized pump light (for example: vertical) and those having a parallel component of other-orientated transition vectors are excited. For
free (unbound) molecules, the rapid rotations contribute to the fluorescence depolarization. In contrast, Cybesin (Cytate) molecules
conjugated to prostate cells contribute to the static fluorescence anisotropy component.
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in prostate tissue. The total time-resolved fluores-
cence intensity of n types of noninteracting














where IðnÞðtÞ, IðnÞ0 , and τðnÞf are the temporal fluores-
cence intensity, initial emission intensity, and life-
time of the nth type of the fluorophore, respectively.
























where rðnÞ0 is the initial anisotropy at t ¼ 0 of the nth
type of the fluorophore.
There are two types of molecules (n ¼ 2) in our
case: cell-bound and -unbound Cybesin (Cytate) mo-
lecules. It is reasonable to assume that they both
have the same fluorescence lifetime [τð1Þf ¼ τð2Þf ]. The
cell-bound contrast agents have infinite rotation
time [τð1Þr → ∞] because they are bound with a huge
tissue cell, and their rotations are too slow in compar-
ison with the rotational time [τð2Þr ] of the unbound
Cybesin (Cytate), which is in the range of picose-
conds. It is also reported that fluorescence intensity
is proportional to the number of fluorophores [21]. By


















where r1 stands for the static anisotropy of cell-
bound Cybesin (Cytate) molecules in prostate tissue.
Using similar procedure of derivation, the perpen-

















Substituting Eqs. (8) and (9) into Eq. (1), the time-
dependent fluorescence anisotropy of contrast agents
becomes:







The temporal profiles of the fluorescence anisotro-
py rðtÞ depends only on r1 (the static anisotropy of
fluorophores), r0 (the initial temporal anisotropy at
t ¼ 0 of the fluorophores), and τr (the dipole’s rotation
time) but not on τf (the fluorophore’s lifetime).
Introducing Eqs. (8) and (9) into IðtÞ ¼
I∥ðtÞ þ 2I⊥ðtÞ, the total time-resolved fluorescence
intensity can be obtained the same as in Eq. (5).
4. Experimental Results and Discussion on Time-
Resolved Measurements
Six Cybesin (Cytate)-stained cancerous and six Cybe-
sin (Cytate)-stained normal prostate tissue samples
were used for the time-resolved fluorescence mea-
surements, respectively. The time-resolved fluores-
cence intensity profiles of I∥ðtÞ and I⊥ðtÞ averaged
over six (6) samples for the cancerous and normal
prostate tissues stained with Cybesin are displayed
in Figs. 2(a) and 2(b), respectively. The thin-dashed
and thin-dotted-curve profiles display the parallel
and perpendicular components, respectively. The
salient feature of Figs. 2(a) and 2(b) is that I∥ is great-
er than I⊥ throughout the decay period for both can-
cerous and normal tissues. At the peak position, I∥ð0Þ
is ∼1:57 times stronger than I⊥ð0Þ for cancerous tis-
sue, while this ratio is ∼1:40 for normal tissue. The
solid lines display the fitting curves calculated using
Fig. 2. (Color online) The time-resolved fluorescence intensity of
light emitted from Cybesin-stained (a) cancerous and (b) normal
prostate tissues with linearly polarized 800nm laser excitation.
The dashed- and dotted-curve profiles display the parallel and per-
pendicular components emitted from stained tissue, respectively.
The solid lines display the fitting curves calculated using Eq. (8)
for the parallel component and Eq. (9) for the perpendicular
component, respectively.
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Eq. (8) for the parallel component, and Eq. (9) for the
perpendicular component, respectively.
The total time-resolved fluorescence intensities
IðtÞ and the temporal profiles of the fluorescence
anisotropy rðtÞ of Cybesin in stained prostate tissue
were calculated using the data of I∥ðtÞ and I⊥ðtÞ
shown in Fig. 2 and Eqs. (5) and (10), respectively.
The calculated results of IðtÞ and rðtÞ are displayed
in Figs. 3(a) and 3(b), respectively. Figure 3(a) indi-
cates that the emission intensity from the Cybesin-
stained cancerous tissue is higher than that from
the Cybesin-stained normal tissue throughout the
lifetime of the Cybesin emission. The emission peak
intensity of the Cybesin-stained cancerous tissue is
much greater than that of the Cybesin-stained nor-
mal tissue. The ratio of peak fluorescence intensities
of Cybesin-stained cancerous tissue to normal pros-
tate tissues is found to be ∼3:29 0:51, indicating
that the cancerous prostate tissue takes up more Cy-
besin than the normal tissue [7,8,10]. The interesting
features of rðtÞ curves shown in Fig. 3(b) are (i) the
values of fluorescence anisotropy of Cybesin in the
stained cancerous tissue are always larger than
those of the stained normal tissue at all the decay
times and (ii) the profile of rðtÞ for the Cybesin-
stained cancerous tissue shows a little flatter decay
in comparison with the normal tissue.
The random rotation of Cybesin (Cytate) molecules
contributed to fluorescence will result in the decay
behavior of rðtÞ. By investigating the time-resolved
fluorescence and anisotropy of emission form Cybe-
sin (Cytate) in prostate tissue, the biophysical micro-
environments of contrast agents can be studied. The
difference of the time-resolved total fluorescence in-
tensity IðtÞ shown in Fig. 3(a), and temporal anisotro-
pies rðtÞ for cancerous and normal prostate tissues
shown in Fig. 3(b) can be quantified by fitting these
experimental data using our analytic model. The
fluorescence lifetime (τf ) and initial peak intensity
(I0) of Cybesin in the stained cancerous and normal
prostate tissues can be obtained by fitting the tem-
poral profiles of the total emission shown in Fig. 3(a)
using Eq. (5). Eqs. (8)–(10), and the temporal profiles
of the polarized fluorescence and anisotropy data
shown in Figs. 2 and 3(b) are used to obtain the pa-
rameters for Cybesin in stained cancerous and
normal prostate tissues: τr (the rotation time), r1 (an-
isotropy of the static component), and r0 (the value of
dynamical anisotropy for the rotation dipoles at
t ¼ 0). The fitting results are shown in Figs. 2 and 3
as solid curves for the cancerous and normal prostate
tissues. The good agreement of our model fitting with
the experimental data indicates that the time-
resolved polarization-dependent fluorescence of the
contrast agent (Cybesin) in human prostate tissue
can be truly considered to have two contributions
from the free Cybesin molecules remaining in the li-
quid of tissue and the static cell-bound Cybesin. The
ratio of peak intensities of total fluorescence for
Cybesin-stained cancerous tissue and normal tissues
(Icancer0 =I
normal
0 ) is ∼3:43 0:54 [7,8,10]. The rotation
time τr and static fluorescence anisotropy r1 for Cy-
besin in cancerous tissue were found to be 1.4 times
and ∼10 times larger than those for normal prostate
tissue, respectively.
The time-resolved polarization fluorescence pro-
files of Cytate in prostate tissue have similar fea-
tures as Cybesin. The parameters of τf , τr, r1, and
r0 for Cytate were analyzed and obtained using
similar procedure as described above. The fitting re-
sults show that the ratio of Icancer0 =I
normal
0 for Cytate-
stained cancerous and normal prostate tissues is
∼3:47 0:57, indicating that cancerous prostate tis-
sue preferential uptakes Cytate than normal tissue
[7,9,11]. The rotation time τr and static fluorescence
Fig. 3. (Color online) (a) The total emission intensity of Cybesin-
stained cancerous (dashed curve) and normal (dotted curve) pros-
tate tissues obtained using the data shown in Figs. 2(a) and 2(b),
and Eq. (5) in the text. The solid lines display the fitting curves
calculated using Eq. (5). (b) Time-dependent fluorescence anisotro-
py calculated using Eq. (1) in the text and the measured data
shown in Figs. 2(a) and 2(b). The dashed and dashed–dotted curve
profiles indicate the rðtÞ for the stained cancerous and normal
prostate tissues, respectively. The fitting curves for Cybesin in
the cancer tissue (thick solid curve) and Cybesin in the normal tis-
sue (thin solid curve) were calculated using Eq. (10) in the text and
the corresponding data shown by the dashed and dashed–dotted
curves in (b).
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anisotropy r1 for Cytate in cancerous tissue were
found to be 1.6 and ∼5 times larger than those for
normal prostate tissue, respectively. These proper-
ties can be explained by the preferential adsorbing
of contrast agents in cancerous tissue and the differ-
ent structure between cancerous and normal pros-
tate tissues [7,9,11].
For convenience, all the experimental and calcu-
lated values of the parameters, r0, r1, τf , and τr for
the two receptor-targeted contrast agents (Cybesin
and Cytate) in the cancerous and normal prostate
tissues are listed in Table 1.
The rotation time (τr) and the lifetime (τf ) of both
Cybesin and Cytate in prostate tissue are in the
same time scale (a few hundred picoseconds), indicat-
ing that time-resolved fluorescence polarization
spectroscopy can be used to investigate rotational dy-
namics [13–15]. The larger r1 observed in Cybesin
(Cytate)-stained cancerous tissue compared with
that in normal tissue (as indicated in Table 1) can
be understood because of more uptake of Cybesin
(Cytate) in cancerous prostate tissue. Furthermore,
because the wavelength of 800nm used for pumping
is close to the strong absorption peak of Cybesin
(Cytate) and cancerous tissue takes up more Cybesin
(Cytate) than the normal tissue [7–11], the stained
cancerous tissue will absorb more photons than
the stained normal tissue. The Cybesin (Cytate) con-
tained in the deep layer of the stained cancerous tis-
sue will have less opportunity to be excited by the
laser than those in the normal tissue. The perpendi-
cular fluorescence component emitted from the Cybe-
sin (Cytate) contained in the stained tissue has a
greater contribution by the photons undergoing a
longer optical path. The light emitted from the
stained normal tissue undergoes more distance
and scattering than that emitted from the stained
cancerous tissue; thus, the r1 values of the stained
cancerous tissue are much larger than those of the
stained normal tissue.
The fitting results also show τcancerr > τnormalr for
both Cybesin and Cytate. This can be understood be-
cause the larger decay time of free (unbound) Cybe-
sin (Cytate) molecules in the cancerous prostate
tissue indicates higher cell density and decreased in-
terstitial spacing between cells in the cancerous tis-
sue compared to the normal tissue, which agrees
with the change of the tissue structure during the
evolution of the malignant tumor [22]. The higher
cell density in the cancerous prostate tissue [12,22]
gives the molecules less “free” rotation space. In ad-
dition, the dye crowds more in the cancerous tissue
due to the fact that more molecules are bound to cell
surfaces through ligands for prostate cancerous tis-
sue. Whether molecules rotate or not, rapid internal
motions due to the flexible structure between con-
trast agent molecules and tissue cells are also re-
sponsible to the decay time of the anisotropy [13,14],
which depends on the ligand strengths. In this point
of view, τcancerr > τnormalr somehow reflects the stronger
conjugation ligand strength andmore cell-bound con-
trast agents in the cancerous prostate tissue than
those in the normal prostate tissue. This may be
the reason behind the larger decay time of Cybesin
(Cytate) in the cancerous prostate tissue compared
to Cybesin (Cytate) in the normal prostate tissue.
5. Fluorescence Polarization Imaging
The preferential uptakes of Cytate (Cybesin) in
cancerous prostate tissue and the polarization pre-
servation property of emission of Cytate (Cybesin)
in prostate tissue can be used to enhance the imaging
contrast between cancerous and normal tissue areas
using fluorescence polarization difference imaging
(FPDI) techniques [23]. In the imaging measure-
ments, a small piece of cancerous prostate tissue and
a small piece of normal prostate tissue stained with
Cytate covered by a large piece of host normal pros-
tate tissue with ∼0:5mm thickness were investi-
gated. The polarized fluorescence images of this
Cytate-stained cancerous/normal prostate tissue
sample recorded with λpump ¼ 750nm and λdetection ¼
850nm are shown in Fig. 4. The parallel image
shown in Fig. 4(a) was recorded when the polariza-
tion direction of detection was parallel (∥) to that
of the illuminating beam. The perpendicular image
shown in Fig. 4(b) was recorded when the polariza-
tion direction of detection was perpendicular (⊥) to
that of the illuminating beam. Figure 4(c) displays
the difference image obtained by subtracting the per-
pendicular image [Fig. 4(b)] from the parallel image
[Fig. 4(a)]. Figures 4(d)–4(f) show the digital spatial
cross-section intensity distributions of the stained
tissue area in the images shown in Figs. 4(a)–4(c),
respectively.
It can be seen from the images that the cancerous
tissue area is much brighter than that of the normal
tissue area. To quantify the difference, the intensity
of the cancerous or normal tissue areas is calculated
as Ic ¼ Imaxc − Ibackground and In ¼ Imaxn − Ibackground, re-
spectively, where Ibackground is the background inten-
sity, and Imaxc and Imaxn are the maximum intensities
of the cancerous and normal tissue areas shown in
Figs. 4(d)–4(f), respectively. The ratio of imaging in-
tensities of cancerous to normal tissue areas is calcu-
lated using the equation of r ¼ 1c=In. Using the
Table 1. Comparison of Time-Resolved Emission Parameters of Cybesin and Cytate in Cancerous and Normal Prostate Tissues
Contrast Agent r1 r0 τf ðpsÞ τr ðpsÞ
Cybesin in cancer 0:056 0:01 0:105 0:01 179 6:8 850 150
Cybesin in normal 0:005 0:01 0:103 0:01 189 11 600 200
Cytate in cancer 0:062 0:013 0:115 0:012 118 2:7 900 180
Cytate in normal 0:014 0:004 0:109 0:030 123 4:9 550 140
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digital data shown in Figs. 4(d) and 4(e), the ratio of
imaging intensities of cancerous-to-normal areas is
found to be ∼3:69 for the parallel image and ∼3:51
for the perpendicular image. These ratios are in good
agreement with that obtained from the time-resolved
fluorescence measurements.
The salient feature is that the relative contrast
of the cancerous to the normal tissue areas in the
polarization difference image shown in Fig. 4(c) is ob-
viously higher than those in the individual polariza-
tion images shown in Figs. 4(a) and 4(b). Using the
digital data shown in Fig. 4(f), the ratio of imaging
intensities of cancerous to normal areas is found to
be ∼4:84 for the FPDI image. The contrasts (C) of the
cancerous area to the normal area for all of the
images shown in Fig. 4 were calculated using:
C ¼ Ic − In
Ic þ In
; ð11Þ
Fig. 4. Contrast agent fluorescence polarization images of a cancerous/normal prostate tissue sample consisting of a tiny Cytate-stained
cancerous and a tiny Cytate-stained normal prostate tissue covered by large pieces of host normal prostate tissue. The images were re-
corded at λpump ¼ 750nm and λdetection ¼ 850nm when the polarization direction in front of the CCD camera is (a) parallel and (b) perpen-
dicular to that of the illuminating light. (c) Polarization difference image obtained by subtracting (b) from (a). (d)–(f) Digital spatial cross
section intensity distributions of the images shown in (a)–(c) at a row crossing the areas of the stained cancerous (C) and normal (N)
tissues, respectively.
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where Ic and In are the local maximum intensities
of the stained cancerous and normal tissue areas,
respectively. Using the digital data shown in
Figs. 4(d)–4(f), the contrasts for these parallel, per-
pendicular, and polarization difference images are
calculated to be 0.57, 0.54, and 0.67, respectively.
In addition, the improvement of the spatial resolu-
tion of the difference image in comparison with the
individual polarization images can be seen from
Figs. 4(d)–4(f). The full-width at half-maximum
(FWHM) for the cancerous tissue area shown in
Fig. 4(f) is improved by a factor of 1.9 with respect
to that of the individual parallel or perpendicular im-
age. The improvement of the spatial resolution of the
difference image can be understood because the
fluorescence polarization difference image canceled
out the strong diffusive component and only kept bal-
listic photons and partial snake photons from the
fluorescent objects [24]. Because the difference of I∥ −
I⊥ for the Cytate-stained cancerous tissue is larger
than that in the Cytate-stained normal tissue, the
contrast between cancerous and normal tissue areas
is improved.
Control experiments between a nonspecific con-
trast agent, ICG, and a specific contrast agent,
Cybesin, were performed as well. NIR spectral polar-
ization imaging experiments were used to demon-
strate if the increased fluorescence seen in
cancerous tissue is truly from the specific targeting
of the corresponding receptor. The experimental
results indicate that ICG-stained prostate cancerous
and normal tissues show trivial difference in the
fluorescence emission images. In addition, Achilefu
et al. at Washington University reported that ICG
does not bind to, leak to, nor localize in bombesin-
and somatostatin-receptor-rich tumor tissues in
animal models in vivo [7].
Prostate cancer is classified as an adenocarcinoma,
or glandular cancer, which is developed from epithe-
lial cells [25]. Of prostate cancer cases, 70% arise in
the peripheral zone. Our methods are concentrated
on layers of cells near the surface, so that a time
of ∼10 min for soaking samples in Cybesin (Cytate)
solution was used [25]. Because of the mean mucosa
thickness of 830 60 μm and the mean rectal wall
thickness of 2:57 0:15mm [26,27], the NIR pump-
ing light of 750 to 800nm can penetrate the rectal
wall to reach the prostate for optical imaging if irra-
diating from the rectum [10,27]. Previous spectral
polarized imaging experiments performed at the In-
stitute for Ultrafast Spectroscopy and Lasers show
that an ICG-stained small object hidden inside the
host prostate tissues in the rectum membrane/pros-
tate structures at depths of 7:5mm can be imaged
and identified using fluorescence imaging methods
[27]. ICG is the fluorescent part of Cybesin and Cy-
tate. It is reasonable to assume that this method may
deal with target depths at several millimeters under
optimal conditions.
6. Conclusion
In summary, an analytical model to describe the
emission behavior of the receptor-targeted contrast
agents, Cybesin and Cytate, in prostate tissue was
developed. A static fluorescence anisotropy compo-
nent formed by the emission of prostate tissue cell-
bound Cybesin (Cytate) molecules (with very slow
rotation), and a time-dependent fluorescence aniso-
tropy component formed by the emission of unbound
Cybesin (Cytate) molecules (with fast rotation) were
determined. This model was successfully used to ex-
plain the experimental results for Cybesin (Cytate)
in stained cancerous and normal prostate tissues.
The static fluorescence anisotropy value of Cybesin
(Cytate) in the stained cancerous tissue was found
to be much larger than that in the stained normal
tissue, indicating more uptake of Cybesin (Cytate)
in the cancerous prostate tissue. The larger rotation
time of Cybesin (Cytate) in the cancerous tissue sug-
gests higher cell density in cancerous tissue com-
pared with the normal tissue. A stronger intensity
of emission from the Cytate-stained cancerous pros-
tate tissue in comparison with the stained normal
tissue was also observed in the fluorescence polariza-
tion imaging measurements, indicating preferential
uptakes of Cytate in the cancerous prostate tissue.
7. Future Work
In order to analyze the time-resolved signals from
overlapped tumor and normal tissues, one first needs
to investigate the picosecond emission spectrum of
cancerous and normal tissue separately. Because
cancerous tissue is usually surrounded by normal tis-
sue, methods need to be developed to handle the mix-
ing signal from both cancerous and normal prostate
tissues to serve the purpose of clinical application in
the future. The methods introduced in this study are
designed to separately obtain the characteristic fea-
ture and profile of each time-resolved emission spec-
trum of the cancerous or normal prostate tissue but
not to handle the double-layer tissue, in which mea-
surements include signals from both the tumor and
normal tissues. This study would provide an impor-
tant basis to decompose the signals from the tumor
and normal tissues. In future research, we are plan-
ning to use blind source separation methods: such as
nonnegative matrix factorization, and multivariate
curve resolution with alternating least-squares [28]
to analyze the mixing time-resolved signals from tu-
mor and normal tissues, and extract their individual
contributions to the measured spectra.
Several biomedical studies are also needed to fol-
low this spectral and optical imaging investigation.
Some immunochemical analysis is needed to identify
the bombesin (somatostatin) receptor subtype that is
targeted by Cybesin (Cytate). The histological ex-
periments for validating the difference of the bombe-
sin (somatostatin) receptors between cancerous and
normal prostate tissues are needed to be performed
by collaborating with biology experts. Some work is
also needed to study if rotational dynamics and
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fluorescence anisotropies can be detectable in situa-
tions for the contrast agents inside and outside cells,
because in viable cells, such as an in vivo situation,
receptor-targeted probes can be internalized by tu-
mor cells. We are planning to investigate this phe-
nomenon in cultured prostate cancer cell lines of
the scattering media and try to figure out a way to
subtract the multiple scattering background in
future research.
Appendix A: Derivation for Simplifying EQ. (A1) to
EQ. (A2)
























There are two types of molecules (n ¼ 2) in our
case: cell-bound and unbound Cybesin (Cytate) mole-
cules. They both have the same fluorescence lifetime
[τð1Þf ¼ τð2Þf ]. The cell-bound contrast agents have infi-
nite rotation time [τð1Þr → ∞] because they are bound
with huge tissue cells, and their rotations are too
slow in comparison with the rotational time [τð2Þr ]
of unbound Cybesin (Cytate), which is in the range


































































Because fluorescence intensity is proportional to
the number of fluorophores in the tissue and the in-
tensity of emission from a single Cybesin (Cytate)
molecule [21], it is reasonable to assume Ið1Þ0 ¼
C · Ið2Þ0 , where C is the proportional coefficient de-
scribing the linear relationship between Ið1Þ0 and I
ð2Þ
0 .
Substituting Ið1Þ0 ¼ C · Ið2Þ0 into I0 ¼ Ið1Þ0 þ Ið2Þ0 , the to-
tal initial intensity can be written as I0 ¼





































































By defining r1 ¼ Crð1Þ0 =ðCþ 1Þ, r0 ¼ rð2Þ0 =ðCþ 1Þ,
τr ¼ τð2Þr [because τð1Þr ¼ ∞, there is only one rotation
time, τð2Þr , that needs to be investigated], the time-
resolved parallel fluorescence component, I∥ðtÞ of


















The expression of I∥ðtÞ as the derived Eq. (A2) is the
same as Eq. (8) in the text.
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